{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T19:29:09Z","timestamp":1793042949294,"version":"4.5.0"},"update-to":[{"DOI":"10.1002\/14651858.cd011990","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2017,11,28]],"date-time":"2017-11-28T00:00:00Z","timestamp":1511827200000}}],"reference-count":135,"publisher":"Wiley","issue":"11","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd011990.pub2","type":"journal-article","created":{"date-parts":[[2017,11,28]],"date-time":"2017-11-28T09:11:37Z","timestamp":1511860297000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":36,"title":["Interventions for preventing oral mucositis in patients with cancer receiving treatment: cytokines and growth factors"],"prefix":"10.1002","volume":"2017","author":[{"given":"Philip","family":"Riley","sequence":"first","affiliation":[{"name":"Division of Dentistry, School of Medical Sciences, Faculty of Biology, Medicine and Health, The University of Manchester; Cochrane Oral Health; JR Moore Building Oxford Road Manchester UK M13 9PL"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne-Marie","family":"Glenny","sequence":"additional","affiliation":[{"name":"The University of Manchester; Division of Dentistry, School of Medical Sciences, Faculty of Biology, Medicine and Health; JR Moore Building Oxford Road Manchester UK M13 9PL"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen V","family":"Worthington","sequence":"additional","affiliation":[{"name":"Division of Dentistry, School of Medical Sciences, Faculty of Biology, Medicine and Health, The University of Manchester; Cochrane Oral Health; JR Moore Building Oxford Road Manchester UK M13 9PL"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Littlewood","sequence":"additional","affiliation":[{"name":"Division of Dentistry, School of Medical Sciences, Faculty of Biology, Medicine and Health, The University of Manchester; Cochrane Oral Health; JR Moore Building Oxford Road Manchester UK M13 9PL"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luisa M","family":"Fernandez Mauleffinch","sequence":"additional","affiliation":[{"name":"Division of Dentistry, School of Medical Sciences, Faculty of Biology, Medicine and Health, The University of Manchester; Cochrane Oral Health; JR Moore Building Oxford Road Manchester UK M13 9PL"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan E","family":"Clarkson","sequence":"additional","affiliation":[{"name":"University of Dundee; Division of Oral Health Sciences; Dental Hospital & School Park Place Dundee Scotland UK DD1 4HR"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin G","family":"McCabe","sequence":"additional","affiliation":[{"name":"The University of Manchester; Division of Cancer Sciences; Manchester Academic Health Science Centre Manchester UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2017,11,28]]},"reference":[{"issue":"6","key":"10.1002\/14651858.CD011990.pub2-BIB0001|cit1","doi-asserted-by":"crossref","first-page":"e348","DOI":"10.1016\/j.eclnm.2009.10.005","article-title":"Protective effect of an enteral formula containing TGF-beta(2) in the prevention of chemotherapy-induced diarrhoea: a pilot study","volume":"4","author":"Antoun","year":"2009","journal-title":"e-SPEN, European e-Journal of Clinical Nutrition and Metabolism"},{"issue":"9","key":"10.1002\/14651858.CD011990.pub2-BIB0002|cit2","doi-asserted-by":"crossref","first-page":"3216","DOI":"10.1182\/blood-2006-04-017780","article-title":"Phase 1\/2 randomized, placebo-control trial of palifermin to prevent graft-versus-host disease (GVHD) after allogeneic hematopoietic stem cell transplantation (HSCT)","volume":"108","author":"Blazar","year":"2006","journal-title":"Blood"},{"issue":"Suppl 2","key":"10.1002\/14651858.CD011990.pub2-BIB0003|cit3","first-page":"S227","article-title":"In a high-dose melphalan setting, palifermin compared to placebo had no effect on oral mucositis or related patient's burden","volume":"19","author":"Blijlevens","year":"2011","journal-title":"Supportive Care in Cancer"},{"issue":"Suppl 1s","key":"10.1002\/14651858.CD011990.pub2-BIB0004|cit4","first-page":"S163","article-title":"Medical resource use of two different dosing regimens of palifermin to prevent mucositis in multiple myeloma patients receiving one-day administration of high-dose melphalan","volume":"46","author":"Blijlevens","year":"2011","journal-title":"Bone Marrow Transplantation"},{"issue":"21","key":"10.1002\/14651858.CD011990.pub2-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1182\/blood.V116.21.904.904","article-title":"Randomized controlled trial of two different dosing regimens of palifermin to prevent mucositis in multiple myeloma patients receiving one-day administration of high-dose melphalan","volume":"116","author":"Blijlevens","year":"2010","journal-title":"Blood"},{"issue":"7","key":"10.1002\/14651858.CD011990.pub2-BIB0006|cit6","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1038\/bmt.2012.257","article-title":"In a high-dose melphalan setting, palifermin compared with placebo had no effect on oral mucositis or related patient's burden","volume":"48","author":"Blijlevens","year":"2013","journal-title":"Bone Marrow Transplantation"},{"issue":"5","key":"10.1002\/14651858.CD011990.pub2-BIB0007|cit7","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1111\/bjh.13086","article-title":"A randomized trial of prophylactic palifermin on gastrointestinal toxicity after intensive induction therapy for acute myeloid leukaemia","volume":"167","author":"Bradstock","year":"2014","journal-title":"British Journal of Haematology"},{"issue":"15","key":"10.1002\/14651858.CD011990.pub2-BIB0008|cit8","doi-asserted-by":"crossref","first-page":"2489","DOI":"10.1200\/JCO.2007.13.7349","article-title":"Phase II study of palifermin and concurrent chemoradiation in head and neck squamous cell carcinoma","volume":"26","author":"Brizel","year":"2008","journal-title":"Journal of Clinical Oncology"},{"issue":"10 Suppl 1","key":"10.1002\/14651858.CD011990.pub2-BIB0009|cit9","first-page":"496a","article-title":"Evaluation of GM-CSF mouthwash for prevention of chemotherapy-induced mucositis: a randomized double-blind dose escalating study","volume":"82","author":"Cartee","year":"1993","journal-title":"Blood"},{"issue":"5","key":"10.1002\/14651858.CD011990.pub2-BIB0010|cit10","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1006\/cyto.1995.0064","article-title":"Evaluation of GM-CSF mouthwash for prevention of chemotherapy-induced mucositis: a randomized, double-blind, dose-ranging study","volume":"7","author":"Cartee","year":"1995","journal-title":"Cytokine"},{"issue":"1","key":"10.1002\/14651858.CD011990.pub2-BIB0011|cit11","doi-asserted-by":"crossref","first-page":"e53252","DOI":"10.1371\/journal.pone.0053252","article-title":"A randomized, non-inferiority study comparing efficacy and safety of a single dose of pegfilgrastim versus daily filgrastim in pediatric patients after autologous peripheral blood stem cell transplant","volume":"8","author":"Cesaro","year":"2013","journal-title":"PLOS One"},{"issue":"Suppl 1s","key":"10.1002\/14651858.CD011990.pub2-BIB0012|cit12","first-page":"S372","article-title":"A non-inferiority study comparing efficacy and safety of a single dose of pegfilgrastim versus daily filgrastim in paediatric patients after autologous peripheral blood stem cell transplant","volume":"47","author":"Cesaro","year":"2012","journal-title":"Bone Marrow Transplantation"},{"issue":"10","key":"10.1002\/14651858.CD011990.pub2-BIB0013|cit13","doi-asserted-by":"crossref","first-page":"2620","DOI":"10.1200\/JCO.1995.13.10.2620","article-title":"Effect of granulocyte-macrophage colony-stimulating factor on oral mucositis in head and neck cancer patients after cisplatin, fluorouracil and leucovorin chemotherapy","volume":"13","author":"Chi","year":"1995","journal-title":"Journal of Clinical Oncology"},{"key":"10.1002\/14651858.CD011990.pub2-BIB0014|cit14","first-page":"428","article-title":"Effect of granulocyte-macrophage colony-stimulating factor (GH-CFS) on oral mucositis in head and neck cancer patients after cisplatin, 5-FU and leucovorin chemotherapy","volume":"13","author":"Chi","year":"1994","journal-title":"Proceedings of the American Society of Clinical Oncology"},{"key":"10.1002\/14651858.CD011990.pub2-BIB0015|cit15","first-page":"442","article-title":"Effect of filgrastim (r-metHuG-CSF) on oral mucositis in patients with small cell lung cancer (SCLC) receiving chemotherapy (cyclophosphamide, doxorubicin and etoposide, CAE)","volume":"13","author":"Crawford","year":"1994","journal-title":"Proceedings of the American Society of Clinical Oncology"},{"issue":"3","key":"10.1002\/14651858.CD011990.pub2-BIB0016|cit16","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1056\/NEJM199107183250305","article-title":"Reduction by granulocyte colony-stimulating factor of fever and neutropenia induced by chemotherapy in patients with small-cell lung cancer","volume":"325","author":"Crawford","year":"1991","journal-title":"New England Journal of Medicine"},{"issue":"4","key":"10.1002\/14651858.CD011990.pub2-BIB0017|cit17","first-page":"187","article-title":"Reduction of oral mucositis by filgrastim (r-metHuG-CSF) in patients receiving chemotherapy","volume":"5","author":"Crawford","year":"1999","journal-title":"Cytokines, Cellular and Molecular Therapy"},{"issue":"4","key":"10.1002\/14651858.CD011990.pub2-BIB0018|cit18","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1093\/annonc\/mdg177","article-title":"Prophylaxis with GM-CSF mouthwashes does not reduce frequency and duration of severe oral mucositis in patients with solid tumors undergoing high-dose chemotherapy with autologous peripheral blood stem cell transplantation rescue: a double-blind, randomized, placebo-controlled study","volume":"14","author":"Dazzi","year":"2003","journal-title":"Annals of Oncology"},{"key":"10.1002\/14651858.CD011990.pub2-BIB0019|cit19","first-page":"167","article-title":"Prophylaxis with GM-CSF mouthwash does not reduce frequency and duration of severe oral mucositis in patients with solid tumors undergoing high dose chemotherapy with autologous PBPC rescue: a double-blind randomized placebo-controlled study","volume":"13 Suppl 5","author":"Dazzi","year":"2002","journal-title":"Annals of Oncology"},{"key":"10.1002\/14651858.CD011990.pub2-BIB0020|cit20","unstructured":"Fink G Ihorst G Burbeck M Kleber M Kohlweyer U Engelhardt M Prospective randomized trial of palifermin (keratinocyte growth factor) versus best supportive care measures (BSC) for the decrease of oral mucositis (OM) in lymphoma patients receiving high-dose BEAM-(BCNU, Etoposide, Ara-C, Melphalan) conditioning and autologous stem-cell transplantation (ASCT) Onkologie. Jahrestagung der Deutschen, \u00d6sterreichischen und Schweizerischen Gesellschaften f\u00fcr H\u00e4matologie und Onkologie; 2011 Sept-Oct 30-04; Basel (Switzerland) Basel (Switzerland) S Karger AG 2011 302"},{"issue":"24","key":"10.1002\/14651858.CD011990.pub2-BIB0021|cit21","doi-asserted-by":"crossref","first-page":"8318","DOI":"10.1158\/1078-0432.CCR-04-1118","article-title":"Phase I\/II randomized trial evaluating the safety and clinical effects of repifermin administered to reduce mucositis in patients undergoing autologous hematopoietic stem cell transplantation","volume":"10","author":"Freytes","year":"2004","journal-title":"Clinical Cancer Research"},{"issue":"4","key":"10.1002\/14651858.CD011990.pub2-BIB0022|cit22","first-page":"343","article-title":"Palifermin and chlorhexidine mouthwashes in prevention of chemotherapy-induced mucositis in children with acute lymphocytic leukemia: a randomized controlled trial","volume":"17","author":"Gholizadeh","year":"2016","journal-title":"Journal of Dentistry (Shiraz, Iran)"},{"issue":"20","key":"10.1002\/14651858.CD011990.pub2-BIB0023|cit23","doi-asserted-by":"crossref","first-page":"2815","DOI":"10.1200\/JCO.2010.32.4103","article-title":"Palifermin decreases severe oral mucositis of patients undergoing postoperative radiochemotherapy for head and neck cancer: a randomized, placebo-controlled trial","volume":"29","author":"Henke","year":"2011","journal-title":"Journal of Clinical Oncology"},{"key":"10.1002\/14651858.CD011990.pub2-BIB0024|cit24","first-page":"S152","article-title":"Palifermin significantly reduces severe oral mucositis in subjects with resected locally advanced head and neck cancer undergoing post-operative concurrent radio-chemotherapy","volume":"88 Suppl 2","author":"Henke","year":"2008","journal-title":"Radiotherapy and Oncology"},{"issue":"1","key":"10.1002\/14651858.CD011990.pub2-BIB0025|cit25","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1002\/hon.2250","article-title":"The efficacy of erythropoietin mouthwash in prevention of oral mucositis in patients undergoing autologous hematopoietic SCT: a double-blind, randomized, placebo-controlled trial","volume":"35","author":"Hosseinjani","year":"2017","journal-title":"Hematological Oncology"},{"issue":"10","key":"10.1002\/14651858.CD011990.pub2-BIB0026|cit26","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1038\/bmt.2011.261","article-title":"Palifermin for the reduction of acute GVHD: a randomized, double-blind, placebo-controlled trial","volume":"47","author":"Jagasia","year":"2012","journal-title":"Bone Marrow Transplantation"},{"issue":"3","key":"10.1002\/14651858.CD011990.pub2-BIB0027|cit27","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1007\/BF00311527","article-title":"Effect of granulocyte colony-stimulating factor (G-CSF) on chemotherapy-induced oral mucositis","volume":"25","author":"Katano","year":"1995","journal-title":"Surgery Today"},{"issue":"21","key":"10.1002\/14651858.CD011990.pub2-BIB0028|cit28","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1182\/blood.V116.21.905.905","article-title":"Interim analysis of randomized phase II study of recombinant human epidermal growth factor on oral mucositis induced by intensive chemotherapy with stem cell transplantation for hematologic malignancies","volume":"116","author":"Kim","year":"2010","journal-title":"Blood"},{"issue":"1","key":"10.1002\/14651858.CD011990.pub2-BIB0029|cit29","doi-asserted-by":"crossref","first-page":"e0168854","DOI":"10.1371\/journal.pone.0168854","article-title":"Topical recombinant human epidermal growth factor for oral mucositis induced by intensive chemotherapy with hematopoietic stem cell transplantation: final analysis of a randomized, double-blind, placebo-controlled, phase 2 trial","volume":"12","author":"Kim","year":"2017","journal-title":"PLOS One"},{"issue":"2","key":"10.1002\/14651858.CD011990.pub2-BIB0030|cit30","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1002\/ajh.23359","article-title":"Recombinant human epidermal growth factor on oral mucositis induced by intensive chemotherapy with stem cell transplantation","volume":"88","author":"Kim","year":"2013","journal-title":"American Journal of Hematology"},{"key":"10.1002\/14651858.CD011990.pub2-BIB0031|cit31","doi-asserted-by":"crossref","first-page":"S32","DOI":"10.1016\/j.ijrobp.2008.06.838","article-title":"Palifermin reduces severe oral mucositis in subjects with locally advanced head and neck cancer undergoing chemoradiotherapy","volume":"72 Suppl 1","author":"Le","year":"2008","journal-title":"International Journal of Radiation Oncology, Biology, Physics"},{"issue":"20","key":"10.1002\/14651858.CD011990.pub2-BIB0032|cit32","doi-asserted-by":"crossref","first-page":"2808","DOI":"10.1200\/JCO.2010.32.4095","article-title":"Palifermin reduces severe mucositis in definitive chemoradiotherapy of locally advanced head and neck cancer: a randomized, placebo-controlled study","volume":"29","author":"Le","year":"2011","journal-title":"Journal of Clinical Oncology"},{"issue":"4","key":"10.1002\/14651858.CD011990.pub2-BIB0033|cit33","first-page":"307","article-title":"Randomised vehicle-controlled dose-finding study of glycosylated recombinant human granulocyte colony-stimulating factor after bone marrow transplantation","volume":"11","author":"Linch","year":"1993","journal-title":"Bone Marrow Transplantation"},{"issue":"4","key":"10.1002\/14651858.CD011990.pub2-BIB0034|cit34","doi-asserted-by":"crossref","first-page":"820","DOI":"10.3109\/10428194.2015.1081192","article-title":"Efficacy and effects of palifermin for the treatment of oral mucositis in patients affected by acute lymphoblastic leukemia","volume":"57","author":"Lucchese","year":"2016","journal-title":"Leukemia and Lymphoma"},{"issue":"1","key":"10.1002\/14651858.CD011990.pub2-BIB0035|cit35","first-page":"43","article-title":"Reliability and efficacy of palifermin in prevention and management of oral mucositis in patients with acute lymphoblastic leukemia: a randomized, double-blind controlled clinical trial","volume":"65","author":"Lucchese","year":"2016","journal-title":"Minerva Stomatologica"},{"issue":"3","key":"10.1002\/14651858.CD011990.pub2-BIB0036|cit36","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/S0360-3016(99)00452-6","article-title":"Granulocyte macrophage-colony stimulating factor (GM-CSF) and sucralfate in prevention of radiation-induced mucositis: a prospective randomized study","volume":"46","author":"Makkonen","year":"2000","journal-title":"International Journal of Radiation Oncology, Biology, Physics"},{"key":"10.1002\/14651858.CD011990.pub2-BIB0037|cit37","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/S0360-3016(99)90196-7","article-title":"Granulocyte macrophage-colony stimulating factor (GM-CSF) and sucralfate in prevention of radiation-induced mucositis: a prospective randomized study","volume":"45 Suppl 3","author":"Minn","year":"1999","journal-title":"International Journal of Radiation Oncology, Biology, Physics"},{"issue":"943","key":"10.1002\/14651858.CD011990.pub2-BIB0038|cit38","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1259\/bjr\/55190439","article-title":"Randomized phase II study of GM-CSF to reduce mucositis caused by accelerated radiotherapy of laryngeal cancer","volume":"79","author":"McAleese","year":"2006","journal-title":"British Journal of Radiology"},{"issue":"8","key":"10.1002\/14651858.CD011990.pub2-BIB0039|cit39","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1200\/JCO.2003.10.079","article-title":"Randomized phase I trial of recombinant human keratinocyte growth factor plus chemotherapy: potential role as mucosal protectant","volume":"21","author":"Meropol","year":"2003","journal-title":"Journal of Clinical Oncology"},{"issue":"6","key":"10.1002\/14651858.CD011990.pub2-BIB0040|cit40","first-page":"949","article-title":"Phase III randomized, double-blind placebo-controlled trial of rhGM-CSF following allogeneic bone marrow transplantation","volume":"15","author":"Nemunaitis","year":"1995","journal-title":"Bone Marrow Transplantation"},{"key":"10.1002\/14651858.CD011990.pub2-BIB0041|cit41","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1200\/jco.2008.26.15_suppl.9514","article-title":"Prophylaxis of recurrent chemotherapy-induced oral mucositis: a phase II multicenter, randomized, placebo-controlled trial of recombinant human intestinal trefoil factor (rhITF)","volume":"26","author":"Barker","year":"2008","journal-title":"Journal of Clinical Oncology"},{"issue":"26","key":"10.1002\/14651858.CD011990.pub2-BIB0042|cit42","doi-asserted-by":"crossref","first-page":"4333","DOI":"10.1200\/JCO.2008.21.2381","article-title":"Phase II, randomized, double-blind, placebo-controlled study of recombinant human intestinal trefoil factor oral spray for prevention of oral mucositis in patients with colorectal cancer who are receiving fluorouracil-based chemotherapy","volume":"27","author":"Peterson","year":"2009","journal-title":"Journal of Clinical Oncology"},{"key":"10.1002\/14651858.CD011990.pub2-BIB0043|cit43","first-page":"383a","article-title":"Recombinant human keratinocyte growth factor (rHuKGF) prevents chemotherapy-induced mucositis in patients with advanced colorectal cancer: a randomized phase II trial","volume":"20 (Pt 1)","author":"Clarke","year":"2001","journal-title":"Proceedings of the American Society of Clinical Oncology"},{"issue":"33","key":"10.1002\/14651858.CD011990.pub2-BIB0044|cit44","doi-asserted-by":"crossref","first-page":"5194","DOI":"10.1200\/JCO.2005.04.1152","article-title":"Palifermin reduces the incidence of oral mucositis in patients with metastatic colorectal cancer treated with fluorouracil-based chemotherapy","volume":"24","author":"Rosen","year":"2006","journal-title":"Journal of Clinical Oncology"},{"issue":"2","key":"10.1002\/14651858.CD011990.pub2-BIB0045|cit45","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/S0360-3016(02)02935-8","article-title":"Comparison of granulocyte-macrophage colony-stimulating factor and sucralfate mouthwashes in the prevention of radiation-induced mucositis: a double-blind prospective randomized phase III study","volume":"54","author":"Saarilahti","year":"2002","journal-title":"International Journal of Radiation Oncology, Biology, Physics"},{"issue":"3","key":"10.1002\/14651858.CD011990.pub2-BIB0046|cit46","first-page":"175","article-title":"Filgrastim (r-metHuG-CSF) and its potential use in the reduction of radiation-induced oropharyngeal mucositis: an interim look at a randomized, double-blind, placebo-controlled trial","volume":"5","author":"Schneider","year":"1999","journal-title":"Cytokines, Cellular and Molecular Therapy"},{"issue":"2","key":"10.1002\/14651858.CD011990.pub2-BIB0047|cit47","first-page":"77","article-title":"Palifermin treatment of mucositis in transplant patients reduces health resource use: phase III results","volume":"2","author":"Emmanouilides","year":"2004","journal-title":"Journal of Supportive Oncology"},{"issue":"2","key":"10.1002\/14651858.CD011990.pub2-BIB0048|cit48","first-page":"73","article-title":"Use of recombinant human keratinocyte growth factor (palifermin) can reduce severe oral mucositis in patients with hematologic malignancies undergoing autologous peripheral blood progenitor cell transplantation after radiation-based conditioning","volume":"2","author":"Spielberger","year":"2004","journal-title":"Journal of Supportive Oncology"},{"issue":"25","key":"10.1002\/14651858.CD011990.pub2-BIB0049|cit49","doi-asserted-by":"crossref","first-page":"2590","DOI":"10.1056\/NEJMoa040125","article-title":"Palifermin for oral mucositis after intensive therapy for hematologic cancers","volume":"351","author":"Spielberger","year":"2004","journal-title":"New England Journal of Medicine"},{"issue":"2","key":"10.1002\/14651858.CD011990.pub2-BIB0050|cit50","first-page":"75","article-title":"Treatment of mucositis with palifermin improves patient function and results in a clinically meaningful reduction in mouth and throat soreness: phase III results","volume":"2","author":"Stiff","year":"2004","journal-title":"Journal of Supportive Oncology"},{"issue":"33","key":"10.1002\/14651858.CD011990.pub2-BIB0051|cit51","doi-asserted-by":"crossref","first-page":"5186","DOI":"10.1200\/JCO.2005.02.8340","article-title":"Palifermin reduces patient-reported mouth and throat soreness and improves patient functioning in the hematopoietic stem-cell transplantation setting","volume":"24","author":"Stiff","year":"2006","journal-title":"Journal of Clinical Oncology"},{"key":"10.1002\/14651858.CD011990.pub2-BIB0053|cit52","first-page":"14S","article-title":"Double-blind, randomized trial of granulocyte-colony stimulating factor (GCSF) versus (v) placebo during postoperative radiation (RT) for advanced resectable squamous cell head and neck cancer (SCCHN): impact on mucositis","volume":"22 Suppl","author":"Su","year":"2004","journal-title":"Journal of Clinical Oncology"},{"issue":"3","key":"10.1002\/14651858.CD011990.pub2-BIB0052|cit53","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1097\/00130404-200605000-00005","article-title":"Double-blind, placebo-controlled, randomized trial of granulocyte-colony stimulating factor during postoperative radiotherapy for squamous head and neck cancer","volume":"12","author":"Su","year":"2006","journal-title":"Cancer Journal"},{"issue":"6","key":"10.1002\/14651858.CD011990.pub2-BIB0054|cit54","doi-asserted-by":"crossref","first-page":"358","DOI":"10.7326\/0003-4819-153-6-201009210-00003","article-title":"Single-dose palifermin prevents severe oral mucositis during multicycle chemotherapy in patients with cancer: a randomised trial","volume":"153","author":"Vadhan-Raj","year":"2010","journal-title":"Annals of Internal Medicine"},{"issue":"15 Suppl","key":"10.1002\/14651858.CD011990.pub2-BIB0055|cit55","doi-asserted-by":"crossref","first-page":"9547","DOI":"10.1200\/jco.2008.26.15_suppl.9547","article-title":"Randomized, double-blind, placebo-controlled study of palifermin for the prevention of mucositis in patients receiving doxorubicin-based chemotherapy","volume":"26","author":"Vadhan-Raj","year":"2008","journal-title":"Journal of Clinical Oncology"},{"issue":"3","key":"10.1002\/14651858.CD011990.pub2-BIB0056|cit56","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1007\/s002770000264","article-title":"Effect of locally applied GM-CSF on oral mucositis after stem cell transplantation: a prospective placebo-controlled double-blind study","volume":"80","author":"Lelie","year":"2001","journal-title":"Annals of Hematology"},{"issue":"15 Suppl","key":"10.1002\/14651858.CD011990.pub2-BIB0057|cit57","doi-asserted-by":"crossref","first-page":"6021","DOI":"10.1200\/jco.2008.26.15_suppl.6021","article-title":"The therapeutic effect of recombinant human epidermal growth factor (rhEGF) on mucositis in patients with head and neck cancer undergoing radiotherapy with or without chemotherapy: a double-blind placebo-controlled prospective phase II multi-institutional study","volume":"26","author":"Ahn","year":"2008","journal-title":"Journal of Clinical Oncology"},{"issue":"1","key":"10.1002\/14651858.CD011990.pub2-BIB0058|cit58","doi-asserted-by":"crossref","first-page":"S32","DOI":"10.1016\/j.ijrobp.2008.06.837","article-title":"The therapeutic effect of recombinant human epidermal growth factor (rhEGF) on mucositis in patients with head and neck cancer undergoing radiotherapy with or without chemotherapy: a double-blind placebo-controlled prospective phase II multi-institutional clinical trial","volume":"72","author":"Lee","year":"2008","journal-title":"International Journal of Radiation Oncology, Biology, Physics"},{"issue":"16","key":"10.1002\/14651858.CD011990.pub2-BIB0059|cit59","doi-asserted-by":"crossref","first-page":"3699","DOI":"10.1002\/cncr.24414","article-title":"Therapeutic effect of recombinant human epidermal growth factor (RhEGF) on mucositis in patients undergoing radiotherapy, with or without chemotherapy, for head and neck cancer: a double-blind placebo-controlled prospective phase 2 multi-institutional clinical trial","volume":"115","author":"Wu","year":"2009","journal-title":"Cancer"},{"issue":"5","key":"10.1002\/14651858.CD011990.pub2-BIB0060|cit60","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1038\/sj.bmt.1703394","article-title":"A phase I\/II double-blind, placebo-controlled study of recombinant human interleukin-11 for mucositis and acute GVHD prevention in allogeneic stem cell transplantation","volume":"29","author":"Antin","year":"2002","journal-title":"Bone Marrow Transplantation"},{"issue":"5","key":"10.1002\/14651858.CD011990.pub2-BIB0061|cit61","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1002\/pbc.20910","article-title":"Protection against chemotherapy induced mucositis by TGF-beta(2) in childhood cancer patients: results from a randomized cross-over study","volume":"48","author":"Koning","year":"2007","journal-title":"Pediatric Blood & Cancer"},{"issue":"4","key":"10.1002\/14651858.CD011990.pub2-BIB0062|cit62","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1097\/00002371-200107000-00014","article-title":"Topical transforming growth factor-beta3 in the prevention or alleviation of chemotherapy-induced oral mucositis in patients with lymphomas or solid tumors","volume":"24","author":"Foncuberta","year":"2001","journal-title":"Journal of Immunotherapy"},{"issue":"2B","key":"10.1002\/14651858.CD011990.pub2-BIB0063|cit63","first-page":"731","article-title":"A prospective randomized trial of thymopentin versus granulocyte-colony stimulating factor with or without thymopentin in the prevention of febrile episodes in cancer patients undergoing highly cytotoxic chemotherapy","volume":"14","author":"Gebbia","year":"1994","journal-title":"Anticancer Research"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD011990.pub2-BIB0064|cit64","first-page":"426","article-title":"Chemotherapy-associated treatment burden in breast cancer patients receiving lipegfilgrastim or pegfilgrastim: secondary efficacy data from a phase III study","volume":"98","author":"Gladkov","year":"2013","journal-title":"Haematologica"},{"key":"10.1002\/14651858.CD011990.pub2-BIB0065|cit65","first-page":"432","article-title":"Effect of granulocyte macrophage colony stimulating factor (GMCSF) on oral mucositis after autologous bone marrow transplantation","volume":"12","author":"Gordon","year":"1993","journal-title":"Proceedings of the American Society of Clinical Oncology"},{"issue":"1","key":"10.1002\/14651858.CD011990.pub2-BIB0066|cit66","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/s00520-006-0105-y","article-title":"Palifermin improves severe mucositis, swallowing problems, nutrition impact symptoms, and length of stay in patients undergoing hematopoietic stem cell transplantation","volume":"15","author":"Horsley","year":"2007","journal-title":"Supportive Care in Cancer"},{"issue":"4 Suppl 2","key":"10.1002\/14651858.CD011990.pub2-BIB0067|cit67","first-page":"52","article-title":"A randomized, double-blind, placebo-controlled, multicenter trial of ATL-104, a swallowable mouthwash, in patients with oral mucositis following peripheral blood stem cell transplantation","volume":"5","author":"Hunter","year":"2007","journal-title":"Journal of Supportive Oncology"},{"issue":"7","key":"10.1002\/14651858.CD011990.pub2-BIB0068|cit68","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1038\/bmt.2008.363","article-title":"Treatment of oral mucositis after peripheral blood SCT with ATL-104 mouthwash: results from a randomized, double-blind, placebo-controlled trial","volume":"43","author":"Hunter","year":"2009","journal-title":"Bone Marrow Transplantation"},{"issue":"8","key":"10.1002\/14651858.CD011990.pub2-BIB0069|cit69","first-page":"1496","article-title":"Intensive short term therapy with granulocyte-macrophage-colony stimulating factor support, similar to therapy for acute myeloblastic leukemia, does not improve overall results for adults with acute lymphoblastic leukemia","volume":"86","author":"Ifrah","year":"1999","journal-title":"American Cancer Society"},{"issue":"8","key":"10.1002\/14651858.CD011990.pub2-BIB0070|cit70","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1016\/S0278-2391(97)90344-X","article-title":"Clinical trial of recombinant granulocyte colony-stimulating factor for chemotherapy-induced neutropenia patients with oral cancer","volume":"55","author":"Iwase","year":"1997","journal-title":"Journal of Oral and Maxillofacial Surgery"},{"issue":"11","key":"10.1002\/14651858.CD011990.pub2-BIB0071|cit71","doi-asserted-by":"crossref","first-page":"2976","DOI":"10.1200\/JCO.1996.14.11.2976","article-title":"Randomized double-blind prospective trial to evaluate the effects of sargramostim versus placebo in a moderate-dose fluorouracil, doxorubicin, and cyclophosphamide adjuvant chemotherapy program for stage II and III breast cancer","volume":"14","author":"Jones","year":"1996","journal-title":"Journal of Clinical Oncology"},{"issue":"8","key":"10.1002\/14651858.CD011990.pub2-BIB0072|cit72","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1038\/sj.bmt.1701434","article-title":"Effect of topical oral G-CSF on oral mucositis: a randomised placebo-controlled trial","volume":"22","author":"Karthaus","year":"1998","journal-title":"Bone Marrow Transplantation"},{"key":"10.1002\/14651858.CD011990.pub2-BIB0073|cit73","first-page":"235","article-title":"Effect of topical oral G-CSF application on oral mucositis in high-grade lymphoma patients treated with hd-methotrexate (hd-mtx) - results of a randomized placebo-controlled trial","volume":"17","author":"Karthaus","year":"1998","journal-title":"Proceedings of the American Society of Clinical Oncology"},{"issue":"4","key":"10.1002\/14651858.CD011990.pub2-BIB0074|cit74","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1111\/bjh.14088","article-title":"A randomized, double-blind trial of pegfilgrastim versus filgrastim for the management of neutropenia during CHASE(R) chemotherapy for malignant lymphoma","volume":"174","author":"Kubo","year":"2016","journal-title":"British Journal of Haematology"},{"issue":"4","key":"10.1002\/14651858.CD011990.pub2-BIB0075|cit75","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1007\/s00520-015-2963-7","article-title":"A randomized, multicenter, phase II\/III study to determine the optimal dose and to evaluate the efficacy and safety of pegteograstim (GCPGC) on chemotherapy-induced neutropenia compared to pegfilgrastim in breast cancer patients: KCSG PC10-09","volume":"24","author":"Lee","year":"2016","journal-title":"Supportive Care in Cancer"},{"issue":"3","key":"10.1002\/14651858.CD011990.pub2-BIB0076|cit76","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1038\/sj.bmt.1700640","article-title":"rhGM-CSF vs placebo following rhGM-CSF-mobilized PBPC transplantation: a phase III double-blind randomized trial","volume":"19","author":"Legros","year":"1997","journal-title":"Bone Marrow Transplantation"},{"issue":"24","key":"10.1002\/14651858.CD011990.pub2-BIB0077|cit77","doi-asserted-by":"crossref","first-page":"4268","DOI":"10.1002\/cncr.28365","article-title":"Phase 1b, multicenter, single blinded, placebo-controlled, sequential dose escalation study to assess the safety and tolerability of topically applied AG013 in subjects with locally advanced head and neck cancer receiving induction chemotherapy","volume":"119","author":"Limaye","year":"2013","journal-title":"Cancer"},{"issue":"1 Suppl","key":"10.1002\/14651858.CD011990.pub2-BIB0078|cit78","first-page":"S259","article-title":"Phase 1B study assessing safety, tolerability and efficacy of AG013 in subjects with head and neck cancer receiving induction chemotherapy","volume":"20","author":"Murphy","year":"2012","journal-title":"Supportive Care in Cancer"},{"issue":"4","key":"10.1002\/14651858.CD011990.pub2-BIB0079|cit79","doi-asserted-by":"crossref","first-page":"268","DOI":"10.3816\/CBC.2002.n.030","article-title":"Phase III trial comparing granulocyte colony-stimulating factor to leridistim in the prevention of neutropenic complications in breast cancer patients treated with docetaxel\/doxorubicin\/cyclophosphamide: results of the BCIRG 004 trial","volume":"3","author":"Nabholtz","year":"2002","journal-title":"Clinical Breast Cancer"},{"key":"10.1002\/14651858.CD011990.pub2-BIB0080|cit80","unstructured":"NCT00360971 Palifermin in lessening oral mucositis in patients undergoing radiation therapy and chemotherapy for locally advanced head and neck cancer clinicaltrials.gov\/show\/NCT00360971"},{"key":"10.1002\/14651858.CD011990.pub2-BIB0081|cit81","unstructured":"NCT00626639 A study of palifermin for the reduction of oral mucositis in patients with locally advanced head and neck cancer receiving postoperative radiotherapy and concurrent chemotherapy clinicaltrials.gov\/show\/NCT00626639"},{"issue":"6","key":"10.1002\/14651858.CD011990.pub2-BIB0082|cit82","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1182\/blood.V80.6.1430.1430","article-title":"Granulocyte colony-stimulating factor to prevent dose-limiting neutropenia in non-Hodgkin's lymphoma: a randomized controlled trial","volume":"80","author":"Pettengell","year":"1992","journal-title":"Blood"},{"issue":"6","key":"10.1002\/14651858.CD011990.pub2-BIB0083|cit83","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1007\/s11136-014-0628-5","article-title":"The impact of concurrent granulocyte-macrophage colony-stimulating factor on quality of life in head and neck cancer patients: results of the randomized, placebo-controlled Radiation Therapy Oncology Group 9901 trial","volume":"23","author":"Hoffman","year":"2014","journal-title":"Quality of Life Research"},{"issue":"3","key":"10.1002\/14651858.CD011990.pub2-BIB0084|cit84","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/j.ijrobp.2006.09.043","article-title":"The impact of concurrent granulocyte macrophage-colony stimulating factor on radiation-induced mucositis in head and neck cancer patients: a double-blind placebo-controlled prospective phase III study by Radiation Therapy Oncology Group 9901","volume":"67","author":"Ryu","year":"2007","journal-title":"International Journal of Radiation Oncology, Biology, Physics"},{"key":"10.1002\/14651858.CD011990.pub2-BIB0085|cit85","doi-asserted-by":"crossref","first-page":"S93","DOI":"10.1016\/0959-8049(95)95684-X","article-title":"Evaluation of the efficacy and safety of GM-CSF in the prophylaxis of mucositis in patients with head and neck cancer treated with RT","volume":"31 Suppl 5","author":"Throuvalas","year":"1995","journal-title":"European Journal of Cancer"},{"issue":"7","key":"10.1002\/14651858.CD011990.pub2-BIB0086|cit86","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.3109\/10428194.2015.1106534","article-title":"Randomized study of granulocyte colony stimulating factor for childhood B-cell non-Hodgkin lymphoma: a report from the Japanese pediatric leukemia\/lymphoma study group B-NHL03 study","volume":"57","author":"Tsurusawa","year":"2016","journal-title":"Leukemia & Lymphoma"},{"issue":"2","key":"10.1002\/14651858.CD011990.pub2-BIB0087|cit87","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1111\/petr.12192","article-title":"Impact of palifermin on incidence of oral mucositis and healthcare utilization in children undergoing autologous hematopoietic stem cell transplantation for malignant diseases","volume":"18","author":"Vitale","year":"2014","journal-title":"Pediatric Transplantation"},{"key":"10.1002\/14651858.CD011990.pub2-BIB0088|cit88","unstructured":"ACTRN12606000083594 Safety and efficacy trial of whey growth factor extract for oral mucositis www.anzctr.org.au\/Trial\/Registration\/TrialReview.aspx?id=1142"},{"key":"10.1002\/14651858.CD011990.pub2-BIB0089|cit89","first-page":"S39","article-title":"Evaluation of the efficacy of granulocyte macrophage colony stimulating factor (GM-CSF) in the prevention of radiation induced mucositis","volume":"48 Suppl 1","author":"Antonadou","year":"1998","journal-title":"Radiotherapy and Oncology"},{"issue":"3 Suppl 1","key":"10.1002\/14651858.CD011990.pub2-BIB0090|cit90","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/S0360-3016(01)02504-4","article-title":"Significance of anemia and role of erythropoietin in radiation induced mucositis in head and neck cancer patients","volume":"51","author":"Elsaid","year":"2001","journal-title":"International Journal of Radiation Oncology, Biology, Physics"},{"issue":"2","key":"10.1002\/14651858.CD011990.pub2-BIB0091|cit91","first-page":"225","article-title":"Effect of locally applied G-CSF on oral mucositis after autogeneic and allogeneic stem cell transplantation","volume":"37","author":"Grzegorczyk-Jazwinska","year":"2006","journal-title":"Acta Haematologica Polonica"},{"issue":"4","key":"10.1002\/14651858.CD011990.pub2-BIB0092|cit92","first-page":"695","article-title":"Effect of locally applied G-CSF on oral mucositis after autologic stem cell transplantation","volume":"41","author":"Grzegorczyk-Jazwinska","year":"2004","journal-title":"Dental and Medical Problems"},{"issue":"Suppl S1","key":"10.1002\/14651858.CD011990.pub2-BIB0093|cit93","first-page":"63","article-title":"Randomized study of granulocyte colony stimulating factor for childhood B-cell non-Hodgkin lymphoma: a report from the Japanese pediatric leukemia\/lymphoma study Group B-NHL03 study","volume":"171","author":"Koga","year":"2015","journal-title":"British Journal of Haematology"},{"key":"10.1002\/14651858.CD011990.pub2-BIB0094|cit94","unstructured":"NCT00293462 GM-CSF mouthwash for preventing and treating mucositis in patients who are undergoing radiation therapy for head and neck cancer clinicaltrials.gov\/show\/NCT00293462"},{"key":"10.1002\/14651858.CD011990.pub2-BIB0095|cit95","unstructured":"NCT00393822 A study of palifermin for the reduction of oral mucositis in subjects with stage 2B or 3 locally advanced, colon cancer clinicaltrials.gov\/show\/NCT00393822"},{"key":"10.1002\/14651858.CD011990.pub2-BIB0096|cit96","unstructured":"NCT02303197 Clinical trial on the efficacy and safety of Chining decoction in the treatment of radiation stomatitis clinicaltrials.gov\/show\/NCT02303197"},{"key":"10.1002\/14651858.CD011990.pub2-BIB0097|cit97","unstructured":"NCT02313792 Palifermin for patients receiving hematopoietic stem cell transplantation clinicaltrials.gov\/show\/NCT02313792"},{"issue":"2","key":"10.1002\/14651858.CD011990.pub2-BIB0098|cit98","first-page":"441","article-title":"Granulocyte colony-stimulating factor in induction treatment of children with non-Hodgkin's lymphoma: a randomized study of the French Society of Pediatric Oncology","volume":"20","author":"Patte","year":"2002","journal-title":"Journal of Clinical Oncology"},{"issue":"4 Suppl 2","key":"10.1002\/14651858.CD011990.pub2-BIB0099|cit99","first-page":"58","article-title":"Final analysis of the phase II, randomized, double-blind, placebo-controlled trial of single-dose velafermin (CG53135-05) for the prevention of oral mucositis","volume":"5","author":"Schuster","year":"2007","journal-title":"Journal of Supportive Oncology"},{"issue":"11","key":"10.1002\/14651858.CD011990.pub2-BIB0100|cit100","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1182\/blood.V110.11.615.615","article-title":"A randomized placebo controlled phase II trial of prevention of severe oral mucositis using single dose velafermin in patients receiving myeloablative therapy and autologous hematopoietic stem cell transplant (AHSCT)","volume":"110","author":"Schuster","year":"2007","journal-title":"Blood"},{"issue":"11 Part 1","key":"10.1002\/14651858.CD011990.pub2-BIB0101|cit101","first-page":"875","article-title":"Evaluation of single-dose palifermin to reduce oral mucositis (OM) in fractionated total body irradiation (fTBI) and high dose (HD) chemotherapy with autologous peripheral blood progenitor cell (PBPC) transplantation","volume":"108","author":"Shea","year":"2006","journal-title":"Blood"},{"issue":"4 Suppl 2","key":"10.1002\/14651858.CD011990.pub2-BIB0102|cit102","first-page":"60","article-title":"Evaluation of single-dose palifermin to reduce oral mucositis in fractionated total-body irradiation and high-dose chemotherapy with autologous peripheral blood progenitor cell transplantation","volume":"5","author":"Shea","year":"2007","journal-title":"Journal of Supportive Oncology"},{"issue":"Pt 1","key":"10.1002\/14651858.CD011990.pub2-BIB0103|cit103","first-page":"7a","article-title":"Efficacy of recombinant human keratinocyte growth factor (rHuKGF) in reducing mucositis in patients with hematologic malignancies undergoing autologous peripheral blood progenitor cell transplantation (auto-PBPCT) after radiation-based conditioning - results of a phase 2 trial","volume":"20","author":"Spielberger","year":"2001","journal-title":"Proceedings of the American Society of Clinical Oncology"},{"issue":"11","key":"10.1002\/14651858.CD011990.pub2-BIB0104|cit104","doi-asserted-by":"crossref","first-page":"3233","DOI":"10.1007\/s00520-013-1900-x","article-title":"Emerging evidence on the pathobiology of mucositis","volume":"21","author":"Al-Dasooqi","year":"2013","journal-title":"Supportive Care in Cancer"},{"issue":"5-6","key":"10.1002\/14651858.CD011990.pub2-BIB0105|cit105","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1081\/CNV-120002497","article-title":"Defining clinically meaningful outcomes in the evaluation of new treatments for oral mucositis: oral mucositis patient provider advisory board","volume":"20","author":"Bellm","year":"2002","journal-title":"Cancer Investigation"},{"issue":"12","key":"10.1002\/14651858.CD011990.pub2-BIB0106|cit106","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.2217\/fon.13.141","article-title":"Mammalian target of rapamycin inhibitor-associated stomatitis","volume":"9","author":"Boers-Doets","year":"2013","journal-title":"Future Oncology"},{"key":"10.1002\/14651858.CD011990.pub2-BIB0107|cit107","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/1745-6215-8-39","article-title":"Standardising outcomes for clinical trials and systematic reviews","volume":"8","author":"Clarke","year":"2007","journal-title":"Trials"},{"issue":"8","key":"10.1002\/14651858.CD011990.pub2-BIB0108|cit108","doi-asserted-by":"crossref","first-page":"e3081","DOI":"10.1371\/journal.pone.0003081","article-title":"Systematic review of the empirical evidence of study publication bias and outcome reporting bias","volume":"3","author":"Dwan","year":"2008","journal-title":"PLOS One"},{"issue":"7109","key":"10.1002\/14651858.CD011990.pub2-BIB0109|cit109","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","article-title":"Bias in meta-analysis detected by a simple, graphical test","volume":"315","author":"Egger","year":"1997","journal-title":"BMJ"},{"issue":"10","key":"10.1002\/14651858.CD011990.pub2-BIB0110|cit110","doi-asserted-by":"crossref","first-page":"2704","DOI":"10.1002\/cncr.23898","article-title":"Patient-reported measurements of oral mucositis in head and neck cancer patients treated with radiotherapy with or without chemotherapy: demonstration of increased frequency, severity, resistance to palliation, and impact on quality of life","volume":"113","author":"Elting","year":"2008","journal-title":"Cancer"},{"issue":"1","key":"10.1002\/14651858.CD011990.pub2-BIB0111|cit111","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/(SICI)1097-0347(199901)21:1<1::AID-HED1>3.0.CO;2-4","article-title":"Quality of life and oral function following radiotherapy for head and neck cancer","volume":"21","author":"Epstein","year":"1999","journal-title":"Head & Neck"},{"issue":"7454","key":"10.1002\/14651858.CD011990.pub2-BIB0112|cit112","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1136\/bmj.328.7454.1490","article-title":"Grading quality of evidence and strength of recommendations","volume":"328","author":"Atkins","year":"2004","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD011990.pub2-BIB0113|cit113","unstructured":"Higgins JP Green S editor(s) Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from handbook.cochrane.org"},{"issue":"2","key":"10.1002\/14651858.CD011990.pub2-BIB0114|cit114","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1111\/jop.12135","article-title":"Oral mucosal injury caused by cancer therapies: current management and new frontiers in research","volume":"43","author":"Jensen","year":"2014","journal-title":"Journal of Oral Pathology and Medicine"},{"issue":"1","key":"10.1002\/14651858.CD011990.pub2-BIB0115|cit115","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.cden.2007.10.002","article-title":"Management of oral mucositis in patients who have cancer","volume":"52","author":"Lalla","year":"2008","journal-title":"Dental Clinics of North America"},{"issue":"10","key":"10.1002\/14651858.CD011990.pub2-BIB0116|cit116","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1002\/cncr.28592","article-title":"MASCC\/ISOO clinical practice guidelines for the management of mucositis secondary to cancer therapy","volume":"120","author":"Lalla","year":"2014","journal-title":"Cancer"},{"key":"10.1002\/14651858.CD011990.pub2-BIB0117|cit117","unstructured":"Lefebvre C Manheimer E Glanville J Chapter 6: Searching for studies. In: Higgins JP, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from handbook.cochrane.org"},{"issue":"17","key":"10.1002\/14651858.CD011990.pub2-BIB0118|cit118","doi-asserted-by":"crossref","first-page":"2914","DOI":"10.1200\/JCO.2009.25.8723","article-title":"Acute myeloid leukemia or myelodysplastic syndrome in randomized controlled clinical trials of cancer chemotherapy with granulocyte colony-stimulating factor: a systematic review","volume":"28","author":"Lyman","year":"2010","journal-title":"Journal of Clinical Oncology"},{"issue":"4","key":"10.1002\/14651858.CD011990.pub2-BIB0119|cit119","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1097\/00002820-200108000-00001","article-title":"Oral care for patients with cancer: a review of the literature","volume":"24","author":"Miller","year":"2001","journal-title":"Cancer Nursing"},{"issue":"6","key":"10.1002\/14651858.CD011990.pub2-BIB0120|cit120","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1002\/cncr.23714","article-title":"Evaluating the supportive care costs of severe radiochemotherapy-induced mucositis and pharyngitis","volume":"113","author":"Nonzee","year":"2008","journal-title":"Cancer"},{"key":"10.1002\/14651858.CD011990.pub2-BIB0121|cit121","doi-asserted-by":"crossref","unstructured":"Peterson DE Srivastava R Lalla RV Oral mucosal injury in oncology patients: perspectives on maturation of a field Oral Diseases 2015 133 41","DOI":"10.1111\/odi.12167"},{"issue":"1","key":"10.1002\/14651858.CD011990.pub2-BIB0122|cit122","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1007\/s00520-012-1594-5","article-title":"Systematic review of cytokines and growth factors for the management of oral mucositis in cancer patients","volume":"21","author":"Raber-Durlacher","year":"2013","journal-title":"Supportive Care in Cancer"},{"issue":"7","key":"10.1002\/14651858.CD011990.pub2-BIB0123|cit123","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD012744","article-title":"Pharmacological interventions for preventing dry mouth and salivary gland dysfunction following radiotherapy","author":"Riley","year":"2017","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"3","key":"10.1002\/14651858.CD011990.pub2-BIB0124|cit124","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1111\/j.1601-0825.2006.01258.x","article-title":"Oral mucositis","volume":"12","author":"Scully","year":"2006","journal-title":"Oral Diseases"},{"issue":"8","key":"10.1002\/14651858.CD011990.pub2-BIB0125|cit125","doi-asserted-by":"crossref","first-page":"2201","DOI":"10.1200\/JCO.2001.19.8.2201","article-title":"Oral mucositis and the clinical and economic outcomes of hematopoietic stem-cell transplantation","volume":"19","author":"Sonis","year":"2001","journal-title":"Journal of Clinical Oncology"},{"issue":"9 Suppl","key":"10.1002\/14651858.CD011990.pub2-BIB0126|cit126","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1002\/cncr.20162","article-title":"Perspectives on cancer therapy-induced mucosal injury: pathogenesis, measurement, epidemiology, and consequences for patients","volume":"100","author":"Sonis","year":"2004","journal-title":"Cancer"},{"issue":"12","key":"10.1002\/14651858.CD011990.pub2-BIB0127|cit127","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1016\/j.oraloncology.2009.08.006","article-title":"Mucositis: the impact, biology and therapeutic opportunities of oral mucositis","volume":"45","author":"Sonis","year":"2009","journal-title":"Oral Oncology"},{"issue":"3","key":"10.1002\/14651858.CD011990.pub2-BIB0128|cit128","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/S0167-8140(02)00404-8","article-title":"Mucositis incidence, severity and associated outcomes in patients with head and neck cancer receiving radiotherapy with or without chemotherapy: a systematic literature review","volume":"66","author":"Trotti","year":"2003","journal-title":"Radiotherapy and Oncology"},{"issue":"1","key":"10.1002\/14651858.CD011990.pub2-BIB0129|cit129","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/s005209900076","article-title":"Efficacy of treatment to relieve mucositis-induced discomfort","volume":"8","author":"Turhal","year":"2000","journal-title":"Supportive Care in Cancer"},{"issue":"6","key":"10.1002\/14651858.CD011990.pub2-BIB0130|cit130","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1007\/s00520-006-0052-7","article-title":"Growth factors and cytokines in the prevention and treatment of oral and gastrointestinal mucositis","volume":"14","author":"B\u00fcltzingsl\u00f6wen","year":"2006","journal-title":"Supportive Care in Cancer"},{"issue":"5","key":"10.1002\/14651858.CD011990.pub2-BIB0131|cit131","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1191\/0962280205sm415oa","article-title":"Outcome selection bias in meta-analysis","volume":"14","author":"Williamson","year":"2005","journal-title":"Statistical Methods in Medical Research"},{"key":"10.1002\/14651858.CD011990.pub2-BIB0132|cit132","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1186\/1745-6215-13-132","article-title":"Developing core outcome sets for clinical trials: issues to consider","volume":"13","author":"Williamson","year":"2012","journal-title":"Trials"},{"issue":"3","key":"10.1002\/14651858.CD011990.pub2-BIB0133|cit133","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1038\/sj.ebd.6401110","article-title":"Priority oral health research identification for clinical decision-making","volume":"16","author":"Worthington","year":"2015","journal-title":"Evidence-based Dentistry"},{"issue":"12","key":"10.1002\/14651858.CD011990.pub2-BIB0134|cit134","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD011990","article-title":"Interventions for preventing oral mucositis in patients with cancer receiving treatment: cytokines and growth factors","author":"Riley","year":"2015","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"4","key":"10.1002\/14651858.CD011990.pub2-BIB0135|cit135","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD000978.pub5","article-title":"Interventions for preventing oral mucositis for patients with cancer receiving treatment","author":"Worthington","year":"2011","journal-title":"Cochrane Database of Systematic Reviews"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cochranelibrary.com\/cdsr\/doi\/10.1002\/14651858.CD011990.pub2\/epdf\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,25]],"date-time":"2023-12-25T03:49:25Z","timestamp":1703476165000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD011990.pub2"}},"subtitle":[],"editor":[{"name":"Cochrane Oral Health Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2017,11,28]]},"references-count":135,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2017,11]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd011990.pub2","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,11,28]]}}}